Oncology
In patients undergoing oncologic diagnostic procedures describing function or diseases where enhanced glucose influx of specific organs or tissues is the diagnostic target. The following indications are sufficiently documented (see also section 4.4).
Diagnosis
- Characterisation of solitary pulmonary nodules
- Detection of cancer of unknown origin, revealed for example by cervical adenopathy, liver or bones metastases
- Characterisation of a pancreatic mass
Staging
- Head and neck cancers including assistance in guiding biopsy
- Primary lung cancer
- Locally advanced breast cancer
- Oesophageal cancer
- Carcinoma of the pancreas
- Colorectal cancer particularly in restaging recurrences
- Malignant lymphoma
- Malignant melanoma, Breslow > 1.5 mm or lymph node metastasis at first diagnosis
Monitoring of therapeutic Response
- Malignant lymphoma
- Head and neck cancers
Detection in case of reasonable suspicion of recurrences
- Glioma with high grade of malignancy (III or IV)
- Head and neck cancers
- Thyroid cancer (non-medullary): patients with increased thyroglobulin serum levels and negative radioactive iodine whole body scintigraphy
- Primary lung cancer
- Breast cancer
- Carcinoma of the pancreas
- Colorectal cancer
- Ovarian cancer
- Malignant lymphoma
- Malignant melanoma
Cardiology
In the cardiologic indication, the diagnostic target is viable myocardial tissue that takes-up glucose but is hypo-perfused, as it must be assessed beforehand using appropriate blood-flow imaging techniques.
- Evaluation of myocardial viability in patients with severe impaired left ventricular function who are candidates for revascularisation when conventional imaging modalities are not contributive.
Neurology
In the neurologic indication the interictal glucose hypometabolism is the diagnostic target.
- Localisation of epileptogenic foci in the presurgical evaluation of partial temporal epilepsy.
Infectious or inflammatory diseases
In infectious or inflammatory diseases, the diagnostic target is tissue or structures with an abnormal content of activated white blood cells. In infectious or inflammatory diseases, the following indications are sufficiently documented:
Localisation of abnormal foci guiding the aetiologic diagnosis in case of fever of unknown origin
Diagnosis of infection in case of:
- Suspected chronic infection of bone and/or adjacent structures: osteomyelitis, spondilitis, diskitis or osteitis including when metallic implants are present
- Diabetic patient with a foot suspicious of Charcot’s neuroarthropathy, osteomyelitis and/or soft tissue infection
- Painful hip prosthesis
- Vascular prosthesis
- Fever in an AIDS Patient
- Detection of septic metastatic foci in case of bacteraemia or endocarditis (see also section 4.4)
Detection of the extension of inflammation in case of:
- Sarcoidosis
- Inflammatory bowel disease
- Vasculitis involving the great vessels
Therapy follow-up
Unresectable alveolar echinococcosis, in search for active localisations of the parasite during medical treatment and after treatment discontinuation.
This medicinal product is for diagnostic use only.
